TLRY
Tilray Brands, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$2.94
+10.97%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$2.79
From 52W high−78.91%
Volume5.87M
Market cap$434.58M
P/E (TTM)—
P/S (TTM)0.5x
Div yield—
Key dataNov 4, 2026
Open
$2.79
From 52W high
−78.91%
Volume
5.87M
Market cap
$434.58M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−30.9x
P/E (TTM)
—
RSI (14)
42.6
MomentumView details →
1D Return
+10.97%
YTD Return
−67.44%
SummaryUpdated Aug 1, 2026
Tilray Brands, Inc. (NASDAQ:TLRY) is a Canadian multinational cannabis and consumer packaged goods company founded in 2013 and headquartered in Leamington, Ontario. Originally established as a medical cannabis producer, Tilray went public in 2018 and has since transformed into a diversified lifestyle brands company through strategic acquisitions and international expansion. The company operates across four main business segments: cannabis, beverage alcohol, distribution, and wellness products, serving markets in over 20 countries including Canada, the United States, Europe, Australia, and Latin America.
Similar companies
Latest newsMore news →
Tilray Brands announced further U.S. beverage-business transformation initiatives targeting approximately $20 million in annualized cost savings by the end of fiscal 2028, after consolidating its U.S. brewing footprint from 10 facilities to six.6d agoTilray Brands, Inc. and Tilray Brands, Inc. unveiled Boleyn Brew, a fan-created beer made for matchday.14d agoTilray Brands, Inc. reported record first-quarter revenue of $257.1 million, up 23% year over year, with gross profit rising 35% to $77.5 million and gross margin expanding to 30% from 27%.27d ago